Gaoshi Zhou

624 total citations
22 papers, 440 citations indexed

About

Gaoshi Zhou is a scholar working on Genetics, Molecular Biology and Epidemiology. According to data from OpenAlex, Gaoshi Zhou has authored 22 papers receiving a total of 440 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Genetics, 11 papers in Molecular Biology and 8 papers in Epidemiology. Recurrent topics in Gaoshi Zhou's work include Inflammatory Bowel Disease (15 papers), Microscopic Colitis (4 papers) and MicroRNA in disease regulation (3 papers). Gaoshi Zhou is often cited by papers focused on Inflammatory Bowel Disease (15 papers), Microscopic Colitis (4 papers) and MicroRNA in disease regulation (3 papers). Gaoshi Zhou collaborates with scholars based in China, United States and Hong Kong. Gaoshi Zhou's co-authors include Shenghong Zhang, Li Li, Zhirong Zeng, Minhu Chen, Peng Chen, Jingxia Lin, Minhu Chen, Yao He, Jing Han and Yun Qiu and has published in prestigious journals such as Nature Communications, Genome biology and Frontiers in Immunology.

In The Last Decade

Gaoshi Zhou

20 papers receiving 437 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gaoshi Zhou China	12	206	188	125	106	79	22	440
Karen Dubois‐Camacho Chile	11	180 0.9×	135 0.7×	73 0.6×	59 0.6×	161 2.0×	20	471
Xuelong Zhang China	14	184 0.9×	122 0.6×	56 0.4×	39 0.4×	89 1.1×	45	448
Linhua Ji China	13	296 1.4×	108 0.6×	150 1.2×	82 0.8×	52 0.7×	35	500
Gregory R. Gipson United States	8	137 0.7×	119 0.6×	48 0.4×	40 0.4×	87 1.1×	17	308
Arianna Ferro Italy	13	238 1.2×	62 0.3×	136 1.1×	134 1.3×	25 0.3×	31	542
Laura Iaffaldano Italy	11	177 0.9×	54 0.3×	101 0.8×	121 1.1×	79 1.0×	14	435
Gerolamo Bevivino Italy	11	116 0.6×	143 0.8×	24 0.2×	77 0.7×	106 1.3×	19	345
Frauke Friedrichs Germany	10	121 0.6×	118 0.6×	44 0.4×	80 0.8×	75 0.9×	16	398
Rachel E. Brown United States	12	180 0.9×	89 0.5×	68 0.5×	61 0.6×	31 0.4×	33	474

Countries citing papers authored by Gaoshi Zhou

Since Specialization

Citations

This map shows the geographic impact of Gaoshi Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gaoshi Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gaoshi Zhou more than expected).

Fields of papers citing papers by Gaoshi Zhou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gaoshi Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gaoshi Zhou. The network helps show where Gaoshi Zhou may publish in the future.

Co-authorship network of co-authors of Gaoshi Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Gaoshi Zhou. A scholar is included among the top collaborators of Gaoshi Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gaoshi Zhou. Gaoshi Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Xie, Zhuo, et al.. (2025). Integrated Single-Cell Transcriptome Analysis Reveals Novel Insights into the Role of Opioid Signaling in the Pathophysiology of Inflammatory Bowel Disease. Biomedicines. 13(6). 1398–1398.

Zhou, Gaoshi, Shuhui Zheng, Guang Yang, et al.. (2025). Transglutaminase 2 modulates inflammatory angiogenesis via vascular endothelial growth factor receptor 2 pathway in inflammatory bowel disease. Journal of Advanced Research. 82. 751–764. 1 indexed citations

Wang, Ying, Jing Han, Guang Yang, et al.. (2024). Therapeutic potential of the secreted Kazal-type serine protease inhibitor SPINK4 in colitis. Nature Communications. 15(1). 5874–5874. 5 indexed citations

Li, Xiaoling, Gaoshi Zhou, Zhuo Xie, et al.. (2023). Role of Rho GTPases in inflammatory bowel disease. Cell Death Discovery. 9(1). 24–24. 8 indexed citations

Xie, Zhuo, Gaoshi Zhou, Jing Han, et al.. (2023). Recent developments on BMPs and their antagonists in inflammatory bowel diseases. Cell Death Discovery. 9(1). 210–210. 13 indexed citations

Huang, Shanshan, Zhuo Xie, Jing Han, et al.. (2023). Protocadherin 20 maintains intestinal barrier function to protect against Crohn’s disease by targeting ATF6. Genome biology. 24(1). 159–159. 14 indexed citations

Wang, Ying, Gaoshi Zhou, Zhuo Xie, et al.. (2023). A Novel Nomogram Combining Mucus Barrier Index for Predicting Treatment Failures in Ulcerative Colitis. Journal of Inflammation Research. Volume 16. 1879–1894. 2 indexed citations

Zhou, Gaoshi, et al.. (2022). Development and validation of a non-invasive biomarker-based model to identify endoscopic recurrences of Crohn’s disease. Therapeutic Advances in Gastroenterology. 15. 1098272072–1098272072.

Lin, Lihui, Ying Li, Gaoshi Zhou, et al.. (2022). Multi-Omics Analysis of Western-style Diet Increased Susceptibility to Experimental Colitis in Mice. Journal of Inflammation Research. Volume 15. 2523–2537. 8 indexed citations

10.

Zhuang, Xiaojun, Baili Chen, Shanshan Huang, et al.. (2022). Hypermethylation of miR-145 promoter-mediated SOX9-CLDN8 pathway regulates intestinal mucosal barrier in Crohn's disease. EBioMedicine. 76. 103846–103846. 15 indexed citations

11.

Xie, Zhuo, Gaoshi Zhou, Lihui Lin, et al.. (2021). Emerging roles of the Hedgehog signalling pathway in inflammatory bowel disease. Cell Death Discovery. 7(1). 314–314. 19 indexed citations

12.

Li, Li, Yingfan Zhang, Gaoshi Zhou, et al.. (2021). A Novel Model Based on Serum Biomarkers to Predict Primary Non-Response to Infliximab in Crohn’s Disease. Frontiers in Immunology. 12. 646673–646673. 13 indexed citations

13.

Li, Ying, Peng Chen, Ying Wang, et al.. (2021). MALAT1 Maintains the Intestinal Mucosal Homeostasis in Crohn’s Disease via the miR-146b-5p-CLDN11/NUMB Pathway. Journal of Crohn s and Colitis. 15(9). 1542–1557. 32 indexed citations

14.

Chen, Peng, Shanshan Huang, Qiao Yu, et al.. (2021). Serum exosomal microRNA-144-3p: a promising biomarker for monitoring Crohn's disease. Gastroenterology report. 10. goab056–goab056. 11 indexed citations

15.

Li, Li, Kang Chao, Qian Cao, et al.. (2020). Platelet-to-lymphocyte percentage ratio index: a simple non-invasive index to monitor the endoscopic activity in Crohn’s disease. Therapeutic Advances in Gastroenterology. 13. 3974168306–3974168306. 5 indexed citations

16.

Lin, Lihui, Gaoshi Zhou, Peng Chen, et al.. (2020). Which long noncoding RNAs and circular RNAs contribute to inflammatory bowel disease?. Cell Death and Disease. 11(6). 456–456. 55 indexed citations

17.

Chen, Peng, Gaoshi Zhou, Jingxia Lin, et al.. (2020). Serum Biomarkers for Inflammatory Bowel Disease. Frontiers in Medicine. 7. 123–123. 134 indexed citations

18.

Zhuang, Xiaojun, Zhenyi Tian, Rui Feng, et al.. (2020). Fecal Microbiota Alterations Associated With Clinical and Endoscopic Response to Infliximab Therapy in Crohn’s Disease. Inflammatory Bowel Diseases. 26(11). 1636–1647. 31 indexed citations

19.

Zhang, Shenghong, Li Li, Shanshan Huang, et al.. (2018). IDDF2018-ABS-0193 Cytokine IL9 mediates the pathogenesis of crohn’s disease through the MIR21-CLDN8 pathway. A11.2–A12. 1 indexed citations

20.

Li, Li, Shanshan Huang, Huiling Wang, et al.. (2018). Cytokine IL9 Triggers the Pathogenesis of Inflammatory Bowel Disease Through the miR21-CLDN8 Pathway. Inflammatory Bowel Diseases. 24(10). 2211–2223. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact